Literature DB >> 33880637

IgG4-related disease with multiorgan involvement: a case-based review.

Nikhil N Tarte1,2, Chandana Shilpa Ravipati3, Jose A Leon de la Rocha4, Elizabeth Rinker4, Nirupa J Patel3.   

Abstract

IgG4-related disease (IgG4-RD) is an immune-mediated multi-organ inflammatory disorder caused by tissue infiltration of lymphocytes with IgG4-secreting plasma cells. Herein, we discuss a case of a patient with IgG4-RD who had involvement of multiple organs: the kidneys, lymph nodes, bone marrow (biopsy performed), lungs, liver, and small intestine (imaging abnormalities). Although several case reports and series of IgG4-RD involving different organ involvement are in the literature, our patient has extensive simultaneous multi-organ involvement. We utilized the four domains (serologic, pathologic, radiologic, and pathologic) as discussed in the new 2019 ACR/EULAR classification criteria to provide a useful framework in considering an alternative tool for IgG4-RD in multi-organ involvement, where biopsy is more invasive and not always accessible. We highlight the findings of each organ involved that increase the likelihood that the patient has IgG4-RD. In our patient, the IgG4-RD classification criteria was fulfilled with total points adding up to 48. Our case meets the classification criteria for IgG4-RD, since at least one organ is involved to meet entry criteria (biopsy proven), no exclusion criteria are present, and the total points are ≥ 20. When such extensive involvement of IgG4-RD occurs, early diagnosis and treatment are recommended to avoid irreversible organ damage and better outcomes.

Entities:  

Keywords:  Anemia; Bone marrow; IgG4-Related disease; Multiorgan; Thrombocytopenia

Year:  2021        PMID: 33880637     DOI: 10.1007/s00296-021-04848-w

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  13 in total

Review 1.  Consensus statement on the pathology of IgG4-related disease.

Authors:  Vikram Deshpande; Yoh Zen; John Kc Chan; Eunhee E Yi; Yasuharu Sato; Tadashi Yoshino; Günter Klöppel; J Godfrey Heathcote; Arezou Khosroshahi; Judith A Ferry; Rob C Aalberse; Donald B Bloch; William R Brugge; Adrian C Bateman; Mollie N Carruthers; Suresh T Chari; Wah Cheuk; Lynn D Cornell; Carlos Fernandez-Del Castillo; David G Forcione; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Gregory Y Lauwers; Yasufumi Masaki; Yasuni Nakanuma; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant V Sahani; Thomas C Smyrk; James R Stone; Masayuki Takahira; George J Webster; Motohisa Yamamoto; Giuseppe Zamboni; Hisanori Umehara; John H Stone
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

Review 2.  IgG4-related disease.

Authors:  Vinay S Mahajan; Hamid Mattoo; Vikram Deshpande; Shiv S Pillai; John H Stone
Journal:  Annu Rev Pathol       Date:  2013-10-02       Impact factor: 23.472

Review 3.  Diagnostic Approach to the Complexity of IgG4-Related Disease.

Authors:  John H Stone; Pilar Brito-Zerón; Xavier Bosch; Manuel Ramos-Casals
Journal:  Mayo Clin Proc       Date:  2015-07       Impact factor: 7.616

Review 4.  IgG4-related kidney disease and retroperitoneal fibrosis: An update.

Authors:  Mitsuhiro Kawano; Takako Saeki; Hitoshi Nakashima
Journal:  Mod Rheumatol       Date:  2019-01-08       Impact factor: 3.023

5.  IgG4-related Disease with Bone Marrow Involvement.

Authors:  Akifumi Ichiki; Norisato Hashimoto; Tomoki Ueda; Shinichiro Hiraiwa; Takuma Tajiri; Naoya Nakamura; Kiyoshi Ando; Kenji Yokoyama
Journal:  Intern Med       Date:  2016-08-15       Impact factor: 1.271

6.  The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.

Authors:  Zachary S Wallace; Ray P Naden; Suresh Chari; Hyon Choi; Emanuel Della-Torre; Jean-Francois Dicaire; Phil A Hart; Dai Inoue; Mitsuhiro Kawano; Arezou Khosroshahi; Kensuke Kubota; Marco Lanzillotta; Kazuichi Okazaki; Cory A Perugino; Amita Sharma; Takako Saeki; Hiroshi Sekiguchi; Nicolas Schleinitz; James R Stone; Naoki Takahashi; Hisanori Umehara; George Webster; Yoh Zen; John H Stone
Journal:  Arthritis Rheumatol       Date:  2019-12-02       Impact factor: 10.995

Review 7.  IgG4-related disease: current challenges and future prospects.

Authors:  David Lang; Jochen Zwerina; Herwig Pieringer
Journal:  Ther Clin Risk Manag       Date:  2016-02-15       Impact factor: 2.423

8.  Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.

Authors:  Mikael Ebbo; Aurélie Grados; Maxime Samson; Matthieu Groh; Anderson Loundou; Aude Rigolet; Benjamin Terrier; Constance Guillaud; Clarisse Carra-Dallière; Frédéric Renou; Agnieszka Pozdzik; Pierre Labauge; Sylvain Palat; Jean-Marie Berthelot; Jean-Loup Pennaforte; Alain Wynckel; Céline Lebas; Noémie Le Gouellec; Thomas Quémeneur; Karine Dahan; Franck Carbonnel; Gaëlle Leroux; Antoinette Perlat; Alexis Mathian; Patrice Cacoub; Eric Hachulla; Nathalie Costedoat-Chalumeau; Jean-Robert Harlé; Nicolas Schleinitz
Journal:  PLoS One       Date:  2017-09-15       Impact factor: 3.240

Review 9.  IgG4-related disease: what a hematologist needs to know.

Authors:  Luke Y C Chen; Andre Mattman; Michael A Seidman; Mollie N Carruthers
Journal:  Haematologica       Date:  2019-01-31       Impact factor: 9.941

10.  IgG4-Related Disease.

Authors:  John H Stone; John K C Chan; Vikram Deshpande; Kazuichi Okazaki; Hisanori Umehara; Yoh Zen
Journal:  Int J Rheumatol       Date:  2013-01-16
View more
  1 in total

Review 1.  Active IgG4-related disease with bone marrow involvement: a report of 2 cases and case-based review.

Authors:  Shiyi Liu; Hui Wang; Tao Su
Journal:  Eur J Med Res       Date:  2022-02-02       Impact factor: 2.175

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.